Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide 10mg Valar Peptides Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine PDF] Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: a randomised, controlled, phase 1b trial. Semantic Scholar Combined GLP 1 amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes Incretin based therapies for the treatment of obesity related diseases npj Metabolic Health and Disease